Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 1, 1977
Synthesis and antiallergic activity of 2-hydroxy-3-nitro-1,4-naphthoquinonesD R Buckle, B C Cantello, H Smith, et al.
The Journal of Trauma|August 1, 1988
The medical and economic impact of severely injured lower extremitiesF J Bondurant, H B Cotler, R Buckle, et al.
Journal of Medicinal Chemistry|February 1, 1983
Studies on v-triazoles. 7. Antiallergic 9-oxo-1H,9H-benzopyrano[2,3-d]-v-triazolesD R Buckle, D J Outred, C J Rockell, et al.
Pulmonary Pharmacology|January 1, 1991
Evaluation of the potassium channel activator BRL 38227 as an inhaled bronchodilator in the guinea-pig: contrast with nifedipine and salbutamolN E Bowring, D R Buckle, G D Clarke, et al.
The Journal of Arthroplasty|June 13, 2001
Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplastyJ E Chelly, J Greger, R Gebhard, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 8, 2001
A proof of principle for targetry to produce ultra high quantities of 18F-fluorideT J Ruth, K R Buckle, K S Chun, et al.
British Journal of Pharmacology|November 1, 1988
Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea-pig: comparison with nifedipineJ R Arch, D R Buckle, J Bumstead, et al.
The Biochemical Journal|November 14, 1997
Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayerS Parvathy, S Y Oppong, E H Karran, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamilS G Taylor, J R Arch, J Bond, et al.
Journal of Medicinal Chemistry|February 1, 1979
Aryloxyalkyloxy- and aralkyloxy-4-hydroxy-3-nitrocoumarins which inhibit histamine release in the rat and also antagonize the effects of a slow reacting substance of anaphylaxisD R Buckle, D J Outred, J W Ross, et al.
Pageof 5